SRSarah Rose

Sarah Rose

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sarah Rose has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Atsuko Hikima

    Neurodegenerative Diseases Research Group, Institute of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, SE1 1UL, UK

    1 shared publication
  • Erika Coletto

    Neurodegenerative Diseases Research Group, Institute of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, SE1 1UL, UK

    1 shared publication
  • Helen M. Cox

    King’s College London London UK

    1 shared publication
  • Iain R. Tough

    Wolfson Centre for Age-Related Diseases, IoPPN, King’s College London, Guy’s Campus, London, SE1 1UL, UK

    1 shared publication
  • K. Ray Chaudhuri

    Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, SE5 8AF, UK

    1 shared publication
  • Mahmoud M. Iravani

    Department of Clinical, Biological and Pharmaceutical Sciences, School of Health, Medicine and Life Sciences, College Lane, University of Hertfordshire, Hatfield, AL10 9AB, UK

    1 shared publication

Latest Publications

  • Open Access

    Dysregulation of epithelial ion transport and neurochemical changes in the colon of a parkinsonian primate

    by Erika Coletto, Iain R. Tough, Sara Pritchard, Atsuko Hikima, Michael J. Jackson, Peter Jenner, K. Ray Chaudhuri, Helen M. Cox, Mahmoud M. Iravani, Sarah Rose

    The pathological changes underlying gastrointestinal (GI) dysfunction in Parkinson’s disease (PD) are poorly understood and the symptoms remain inadequately treated. In this study we compared the functional and neurochemical changes in the enteric nervous system in the colon of adult, L-DOPA-responsive, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmoset, with naïve controls. Measurement of mucosal vectorial ion transport, spontaneous longitudinal smooth muscle activity and immunohistochemical assessment of intrinsic innervation were each performed in discrete colonic regions of naïve and MPTP-treated marmosets. The basal short circuit current (Isc) was lower in MPTP-treated colonic mucosa while mucosal resistance was unchanged. There was no difference in basal cholinergic tone, however, there was an increased excitatory cholinergic response in MPTP-treated tissues when NOS was blocked with L-Nω-nitroarginine. The amplitude and frequency of spontaneous contractions in longitudinal smooth muscle as well as carbachol-evoked post-junctional contractile responses were unaltered, despite a decrease in choline acetyltransferase and an increase in the vasoactive intestinal polypeptide neuron numbers per ganglion in the proximal colon. There was a low-level inflammation in the proximal but not the distal colon accompanied by a change in α-synuclein immunoreactivity. This study suggests that MPTP treatment produces long-term alterations in colonic mucosal function associated with amplified muscarinic mucosal activity but decreased cholinergic innervation in myenteric plexi and increased nitrergic enteric neurotransmission. This suggests that long-term changes in either central or peripheral dopaminergic neurotransmission may lead to adaptive changes in colonic function resulting in alterations in ion transport across mucosal epithelia that may result in GI dysfunction in PD.